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ABSTRACT
Acute cardiopulmonary failure after emergency coronary artery bypass grafting (CABG) is a complex thera-
peutic problem due to its high mortality rate. This paper reports the safety and effectiveness of extracorpor-
eal membrane oxygenation (ECMO) in treating acute cardiopulmonary failure following emergency CABG. 
A 37-day period of mechanical circulation support and extracorporeal blood oxygenation with the ECMO 
method served as a bridge to recovery. At day 34 following the disconnection of ECMO, a patient with 
EF > 35% was transferred to a rehabilitation ward. The procedure can be successful only when the physi-
cians, nurses and perfusionists of the intensive care team cooperate closely.
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INTRODUCTION
Acute cardiopulmonary failure is a complex thera-
peutic problem due to its high mortality rate. The 
biggest threat to the survival of a patient in acute 
cardiopulmonary failure is a low cardiac output, 
as well as the high ventilation pressures and high 
oxygen concentrations being used. In the clinical 
practice, when cardiosurgery has proved unsuccess-
ful, the standard treatment is to apply an intensive 
medical treatment with potent pressure agents and 
intra-aortic balloon counterpulsation, (IABP) [1]. 
Depending on how a particular ward is equipped, 
the treatments available also include ECMO (Extra-
corporeal Membrane Oxygenation). This method, 
applied at the right moment, i.e. before irreversible 
organ changes occur, provides an opportunity to 
save and prolong life. Depending on which proce-
dural strategy is chosen, ECMO can be used in one 
of the three following ways: as a bridge to making 
a decision; as a bridge to transplantation; or as 
a bridge to recovery [2]. There are two main types 
of cannulating a patient so that he/she will be con-
nected into the ECMO system [3]: veno-venous can-
nulation, which is used in respiratory failure without 
the heart failure component; and arterio-arterial 
cannulation, used in respiratory failure in a patient 
unstable hemodynamically. The cannulation used 
in ECMO can either be percutaneous [2] or via an 
open surgical approach [4].
The subject of the paper presented here is to 
prove the safety and effectiveness of ECMO in treat-
ing acute cardiopulmonary failure after CABG, as 
a bridge to recovery.
CASE 
A 53-year-old man, with a negative history of cardi-
ovascular diseases, was admitted to our hospital in 
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June 2014. The diagnosis was acute coronary syn-
drome — inferior wall STEMI (ST elevation mycoradial 
information). Following emergency coronarography, 
an attempt was made to open the right coronary ar-
tery — the procedure was unsuccessful, complicated 
by the occlusion of the right coronary branch. Echo-
cardiography revealed the following: a normal size of 
the left ventricle (LV); a large akinesis of the LV mus-
cle; hypokinesis of the distal parts of the inferolateral 
and anterolateral walls; and substantial hypokinesis 
of the proximal part of the anterolateral wall. Ejec-
tion fraction (EF) was around 15%. Despite intensive 
treatment, the condition of the patient gradually de-
teriorated — there were several episodes of paroxys-
mal atrial fibrillation and flutter. On the 7th day after 
STEMI, the patient had a sudden cardiac arrest with 
asystole and on two occasions ventricular fibrillation 
terminated with external defibrillation. 
The patient underwent an off-pump coronary ar-
tery bypass graft (CABG): left internal mammary ar-
tery (LIMA) — left anterior descending artery (LAD), 
saphenous vein (SV) — right coronary artery (RCA). 
Once the patient was transferred to a post-operative 
ward, he underwent analgosedation and was ven-
tilated mechanically with synchronized intermittent 
mandatory ventilation (SIMV) — fraction of inspired 
oxygen (FiO2) was 0.6, the circulation was stabilized 
with continuous infusions of dobutamine and nitro-
glycerin achieving RR 150/80 mm Hg, sinus rhythm 
95 bpm and spontaneous diuresis.
By the end of day 4 following CABG, the patient 
was woken up and fully conscious, extubated, with 
only passive oxygen therapy used. There were nu-
merous episodes of ventricular fibrillation (VF) ter-
minated by defibrillation and he regained conscious-
ness after interventions. Antiarrhythmic treatment 
with amiodarone and lidocaine was performed in 
the form of permanent infusion. EF was around 
10%. A balloon for intra-aortic counterpulsation 
was implanted, yet no hemodynamic stability was 
achieved. In the face of acute cardiopulmonary fail-
ure which did not respond to standard treatment, 
the decision was made to apply extracorporeal arte-
rio-venous oxygenation ECMO. A POL-VAD cannula 
was inserted into the right atrium, an arterial cannu-
la was connected to the aorta. A vent was inserted 
into the left ventricle via the right upper pulmonary 
vein. In this way a very good venous outflow was 
established, which fully relieved the burden on the 
heart. The patient was under balanced anaesthesia. 
During the procedure there were several sudden 
cardiac arrests due to VF, which were successfully 
terminated by defibrillation. Once the patient was 
connected to ECMO, his condition became stable, 
which made it possible to reduce catecholamines 
and to balance metabolic asidosis. The patient was 
ventilated mechanically with SIMV FiO2 0.4, ECMO 
— CO 5.0 achieving MABP > 90 mm Hg (Fig. 1, 2). 
On the 5th day after CABG, the patient under-
went reoperation because of bleeding (hct 18.6%, 
Hb 6.12 g/dl). Sedation was achieved with an i.v. 
infusion of sodium thiopental. ECMO was closely 
monitored and maintained by a perfusionist team 
during the entire duration of support. The support 
system was monitored daily for thrombi and fibrin 
deposits. 
Between days 6 and 11 following CABG, the 
patient underwent analgosedation (dexmedetomi-
dine + sufentanil) together with protective mechan-
FIGURE 1. Extracorporeal Membrane Oxygenation
FIGURE 2. Membrane-Oxygenator of Extracorporeal Membrane 
Oxygenation
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ical ventilation — SIMV FiO2 0.3. Positive end-expir-
atory pressure (PEEP) was 6 mm H2O. There were 
numerous episodes of VT and VF, some of which 
terminated spontaneously; others were defibrillated 
with the lowest effective energy of 50J. IABP was re-
moved. Because of an increasing number of thrombi 
seen in the oxygenator, an additional unfraction-
ated heparin infusion monitored by the aPTT was 
carried out. Due to elevated inflammatory parame-
ters, namely C-reactive protein (CRP) — 17.32 mg/dl; 
N:  0–0.5 mg/dl, empirical therapy with antibiotics 
was introduced: Ceftriaxone + Gentamicin. The flu-
id balance was kept negative. Bloody secretion was 
present in the respiratory tract, and since the ECMO 
cannula ports were bleeding, they had to be treated 
surgically. The laboratory test findings were as fol-
lows: NT-pro BNP 6767.0 pg/ml; N: 0–125 pg/ml. 
Kidney and liver parameters remained normal. Total 
parenteral nutrition (TPN) was begun. The ECMO set 
was exchanged at the bedside and in sterile condi-
tions due to clot formation in the ventricular vent. 
Bedside rehabilitation was carried out.
Between days 17 and 22 following CABG, the 
patient developed extensive bleeding from the bron-
chi, nose and throat. A bronchofiberoscopy, along 
with anterior and posterior tamponade of the nose, 
were carried out several times. Enteral feeding with 
commercial mixture through a stomach probe was 
introduced and TPN continued. Sedation with dex-
medetomidine was introduced. As the cultures col-
lected yielded meticilline-sensitive staphylococcus, 
ceftriaxon was continued. Circulation support ECMO 
CO 3.0. The inflammatory parameters were elevat-
ed — CRP was 31.4 mg/dl. The laboratory findings 
were as follows: D-dimer 93.03 μ/ml; N: 0–0.5 μ/ml; 
troponin T — 432.40 ng/l; N: 0–14 ng/l.
On day 38 after CABG, the patient underwent 
a transesophageal echocardiography (TEE): the left 
ventricle was undilated — 52 mm in diastole, ak-
inesis of the inferior wall and septum, contractil-
ity of the postero-lateral wall preserved. EF was 
40–45%. The right ventricle was 39 mm in 4 CH, 
while there was akinesis of the basal segment of 
the RV free wall, better contractility of defibrillating 
lead in right ventricle outflow tract (RVOT) and the 
apex. The patient was extubated and placed under 
passive oxygen therapy through a Venturi oxygen 
mask. In gasometry, the patient’s breathing was 
seen to have low efficiency (pO2 — 64.9 mm Hg, 
pCO2 — 37.6 mm Hg). Secretions from the bronchi 
had to be sucked out from time to time, while fe-
ver reached 39°C. Culture from the bronchi yielded 
pseudomonas aeruginosa, which led to meropenem 
being introduced.
On day 42 following CABG, after a follow-up 
TEE with preliminary heart burdening, as it was 
impossible to control the bleeding associated with 
antithrombotic therapy applied in ECMO, the pa-
tient was disconnected from ECMO, although the 
risk for complications was very high. The procedure 
was performed in an operating room. In the intraop-
erative period the patient had to be stabilized with 
catecholamines — levosimendan and dobutamine 
infusion. The patient was ventilated mechanically: 
CMV FiO2 0.7. Cardiac index (CI) was monitored 
permanently: CI — 3.6. During the 3rd hour after 
the procedure, the patient was conscious with log-
ical contact, extubated and supported with passive 
oxygen therapy. The patient underwent intensive 
breathing physiotherapy due to large secretion de-
posits in the bronchi and difficulties in coughing to 
clear the bronchi. 
Between days 44 and 58 after CABG, there were 
several episodes of respiratory failure which had to 
be treated with mechanical ventilation. The circu-
latory system was temporarily stabilized with cat-
echolamine infusion — dobutamine and milrinon 
while CI was 3.4. Since a fever of up to 40°C and 
elevated inflammatory parameters (CRP 25.5 mg/dl) 
kept recurring, antibiotics (imipenem and colistin) 
were used. Once another series of microbiologi-
cal test findings (including staphylococcus aureus 
and pseudomonas aeruginosa) were available, the 
treatment was changed to meronem + vancomycin 
followed by gentamycin, colistin and vancomycin. 
Although initially the patient found it difficult to 
swallow, oral nutrition was introduced. Intensive 
rehabilitation was continued, with attempts to make 
the patient sit up, then walk — first with support, 
then by himself.
On the 76th day after CABG, the patient with 
normal inflammatory parameters (CRP 0.9 mg/dl), 
satisfactory breathing and circulation, and being 
conscious with logical contact, was transferred to 
a rehabilitation ward. In echocardiography, the left 
ventricle cavity was slightly dilated — 58 mm in dias-
tole while the muscle thickness was normal. Akinesis 
of the inferior wall and interventricular septum, lat-
eral wall contractility was preserved. EF was around 
35% while LVOT VTI was 10 cm. The left atrium was 
dilated. Regarding, the right ventricle, the inflow 
part was slightly dilated (43 mm) with very impaired 
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contractility, s’4 cm/s, there was akinesis of the basal 
segment of the right ventricle free wall, with slightly 
better contractility of the apex. More than small IT. 
RVSP was around 25 mm Hg. 
DISCUSSION 
The paper reports the successful application of 
ECMO as a method of a prolonged mechanical 
post-CABG support in acute cardiopulmonary failure 
(37 days). The ECMO method provided heart muscle 
regeneration via temporary support of the circulato-
ry system, which created a possibility for the heart 
muscle to compensate and regenerate after CABG 
— Figure 3. In a series of echographic examinations, 
EF was observed to improve from < 10% at the time 
before ECMO was applied to 35% at the time of dis-
charge from the ICU. The weaning process of such 
patients can be very difficult, slow, and challenging. 
This case, to the best of our knowledge, illustrates 
the first reported successful veno-arterial ECMO in 
a patient as bridge to recovery in post-CABG car-
diogenic shock associated with a dramatically poor 
patient condition. Owing to the fact that ECMO 
was applied at an early stage, no organ hyperper-
fusion occurred. Inotropic agents were reduced to 
a minimum to allow for optimal myocardial recovery 
while still maintaining left ventricular ejection. Due 
to the protective action of ECMO the patient was 
not exposed to large, toxic doses of catecholamines 
— during the whole of the follow-up, both kidney 
and liver parameters were normal. 
Early post emergency CABG care is still a chal-
lenge for therapeutic teams. Biancari et al. [5] report-
ed that in a group of 596 patients after emergency 
CABG, the mortality rate was around 10%. In the 
authors’ opinion, the principal independent risk fac-
tors which negatively affected the survival of post-
CABG patients were: increasing emergency CABG 
classes (p < 0.0001); recent myocardial infarction 
(p = 0.019); left ventricular ejection fraction ≤ 30% 
(p = 0.034); on-pump surgery (p = 0.012); and 
participating centres (p < 0.0001). Several studies 
have demonstrated mortality rates of 50% to 84% 
among patients requiring ECMO support after cardi-
othoracic surgery. Postcardiotomy cardiogenic shock 
occurs in approximately 1–1.5% of patients [6, 7]. 
The study by Rastan et al. [7], in which the analysis 
comprised 517 consecutive adult patients treated 
with extracorporeal membrane oxygenation for re-
fractory postcardiotomy cardiogenic shock, showed 
that overall hospital survival was 24.8%, at a mean 
ejection fraction of 45.9% ± 17.6% and logistic Eu-
ro-SCORE of 21.6% ± 20.7%. The risk factors for 
hospital mortality show that isolated coronary artery 
bypass grafting (odds ratio, 0.44) was protective 
with 34.7% hospital survival. In a study by Doll et 
al. [8], 219 patients who needed a postoperative 
ECMO support (refractory postoperative cardiogenic 
shock) were retrospectively analyzed. For this patient 
group there were substantial in-hospital (76%) and 
5-year follow-up mortality rates (82%). In a group 
of 119 patients after CABG supported by ECMO, 
the 30-day mortality rate was 61%. The poorest 
results were among patients undergoing combined 
CABG and aortic valve replacement with mortality 
rate of 95%. In the study mentioned above, the 
independent predictors of in-hospital survival were 
FIGURE 3. Graph depicting changes in Troponin T concentrations during the patient’s postoperative follow-up
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as follows: younger age; absence of preoperative 
myocardial infarction; absence of diabetes; the use 
of an intra-aortic balloon pump; and whether the 
procedures performed prior to ECMO were valve, 
CABG, or valve/CABG. In the case presented here, 
the patient had all of the risk factors itemized by 
Doll et al. This proves the presented case is unique 
as it points out the potential benefits resulting from 
a prolonged ECMO support. 
The most common complications associated 
with ECMO include hemostasis disorders causing 
bleeding resulting from the necessity to apply hepa-
rin constantly [9]. The patient reported here, during 
his hospitalization, had 49 units of RBC concentrate 
transfused. This was the result of bleeding from 
the oral cavity and throat, which was difficult to 
manage. All transfused RBC preparations were leu-
koreduced and irradiated. 
In such circumstances it is quite a challenge to 
maintain balanced APTT, while simultaneously pre-
venting clot formation in the ECMO system without 
affecting bleeding substantially. Our patient, while 
undergoing ECMO therapy, was at minimally accept-
able APTT times — 40–50 sec. Golding et al. [10] 
reported a mean transfusion rate of 53.2 of packed 
red blood cell units/patient and a rethoracotomy rate 
of 87.3% among 91 patients undergoing ECMO. In 
the study by Rastan et al., the mean perioperative 
red blood cell transfusion rate was 13 units/patient 
during the first 48 hours of ECMO support [7].
At present, the patient is 20 months after heart 
surgery, in good general condition, with no neuro-
logical complications, in NYHA class II. 
CONCLUSION
The procedure can be successful only when the 
members of the intensive care team — physicians, 
paramedics, nurses, percussionists — cooper-
ate closely.
In the centre presented here, this was the 24th 
procedure of ECMO used in 2014. The resultant 
experience makes it possible to use highly special-
ized medical equipment optimally, in cases whose 
mortality risk exceeds 90%.
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